New Attack on GM Food Safety Testing Standards
New Attack on GM Food Safety Testing
Standards
Wednesday, February 07, 2007
Australian and
New Zealand regulators are failing to resist an audacious
bid by GM plant developers to have them abandon a
fundamental principle
of food safety testing.
The
internationally accepted baseline for assessing the safety
of a GM
food is to conduct studies that consistently
compare it with the
closest non-GM relative. Such a
'comparator' is considered the standard because
of its
long history of safe use as a food for people.
Last
December, Food Standards Australia New Zealand (FSANZ)
recommended
approving a new GMO as safe for human
consumption even though the
studies submitted in support
of its safety compared it to another GMO
variety that has
no history of safe use. The Minister for Food
Safety,
Annette King, now has just 5 days left to respond
to that
recommendation.
The GMO in question is
Monsanto's 'high lysine' GM corn (called LY038),
an
animal feed that is unlike any GM corn varieties
commercialised to
date due to its substantially different
nutritional profile.
There are compelling reasons to
believe that LY038 could produce a
unique spectrum of
food hazards because LY038 has extremely
high
concentrations of the free amino acid lysine and its
derivatives. When
cooked, these substances may form
chemicals that are strongly
implicated
in causing
certain diseases or their symptoms, including
diabetes,
Alzheimer's and cancer.
Monsanto is seeking
approval for this animal feed to be a legal human
food
because of the difficulty of preventing it from entering the
food
chain. FSANZ claims that if approved, only very
small proportions of
the
new corn would become human
food. However, even small quantities
of
such
substances pose food safety risks and once
approval is given, there is
no upper limit on the
proportion of LY038 corn that can legally enter
the human
food supply.
The deeper issue is the precedent-setting
nature of any decision to
approve a new GMO on the basis
of studies that do not consistently test
it against its
conventional counterpart. If New Zealand and
Australia
deem that abandoning the international standard
is acceptable in this
case, they may lose the ability to
use it to challenge future GM crops
that also rely on
GMOs as test comparators.
Further, once one GM
bio-industrial product is accepted as a food on
this
basis, the stage is set for a raft of other products -
including
plants producing industrial and medical
substances - to be approved
using this lower safety
standard. The novelty of this wave of new GMOs
should be
driving adherence to the highest standards, rather than
the
breach of a key safety principle.
The minister
should use her statutory powers to require FSANZ
to
undertake a review and seek to have Monsanto provide
new safety studies
using the appropriate non-GM
comparator (a corn variety called H99 that
is the closest
non-GMO relative of LY038). This is consistent with
the
approach set out in Codex guidelines and is a
principle that should not
be abandoned.
Ends